Skip to main content

Year: 2022

Horizon Therapeutics plc

                        FORM 8.3   IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE   1. KEY INFORMATION  Name of person dealing (Note 1) State Street Global Advisors & AffiliatesCompany dealt in Horizon Therapeutics plcClass of relevant security to which the dealings being disclosed relate (Note 2) $0.0001 ordinary sharesDate of dealing 28th Nov 2022       2. INTERESTS AND SHORT POSITIONS   (a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)    Long Short  Number (%) Number (%)(1) Relevant securities 5,905,507 2.60519%    (2) Derivatives (other than options) 508 0.000224%    (3) Options and agreements to purchase/sell N/A N/A    Total 5,906,015 2.60541%        (b)...

Continue reading

SeaStar Medical Bolsters Operational Expertise with Appointment of Thomas R. Mullen as Vice President of Operations and Product Development

DENVER, COLORADO, Dec. 02, 2022 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq:ICU), (“SeaStar Medical” or the “Company”), a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, today announced the appointment of Thomas R. Mullen as Vice President of Operations and Product Development. Mr. Mullen is a proven medical device professional with 30 years of experience leading business operations, manufacturing, engineering, product development and regulatory remediation. “SeaStar Medical has continued to evolve and remains on a trajectory of growth including near-term potential for commercialization. As we continue our preparations for success in treating both acute and chronic illnesses through advanced product offerings, we believe Tom’s extensive...

Continue reading

HIGHCO: Shareholding as 11-30-2022

INFORMATION CONCERNING THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES Declaration pursuant to Articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulations of the Autorité des marchés financiers (AMF)Date of settlementof information Total number of shares Number of shares without voting rights (*) Number of voting rights for threshold calculation (**) Number of actual voting rights (exercisable at shareholders’ meeting)November 30, 2022 20 455 403 177 280 23 012 201 22 834 921October 31, 2022 20 455 403 145 022 23 048 421 22 903 399September 30, 2022 20 455 403 90 180 23 050 521 22 960 341August 31, 2022 20 455 403 83 843 23 050 522 22 966 679July 31, 2022 20 455 403 82 029 23 050 622 22 968 593July 2, 2022 (***) 20 455 403 78 771 23 050 722 22 971 951June 30, 2022 22 421 332 2 044 700 25 016...

Continue reading

Skyharbour Resources Receives $895,000 from Warrant Exercises

Vancouver, BC, Dec. 02, 2022 (GLOBE NEWSWIRE) — Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (the “Company”) is pleased to announce it has received an aggregate CAD $895,027.32 from the exercise of share purchase warrants with a strike price at $0.22 since June 29th, 2022. A total of 4,068,306 warrants have been exercised with this batch of warrants expiring November 29th, 2022. About Skyharbour Resources Ltd.: Skyharbour holds an extensive portfolio of uranium exploration projects in Canada’s Athabasca Basin and is well positioned to benefit from improving uranium market fundamentals with fifteen projects, ten of which are drill-ready, covering over 450,000 hectares of land. Skyharbour has acquired from Denison Mines, a large strategic shareholder of the Company, a 100% interest in the Moore Uranium...

Continue reading

Stran & Company Signs Definitive Agreement to Acquire Premier NYC

Premier NYC brings established customer base and over 30 years of experience in the industry Quincy, MA, Dec. 02, 2022 (GLOBE NEWSWIRE) — Stran & Company, Inc. (“Stran” or the “Company”) (NASDAQ: STRN) (NASDAQ: STRNW), a leading outsourced marketing solutions provider that leverages its promotional products and loyalty incentive expertise, today announced the signing of a definitive asset purchase agreement to acquire Premier Business Services, an established promotional products company formed by Peter Poser in 1988 and headquartered in Larchmont, New York (“Premier NYC”). The acquisition is expected to close this month and is subject to customary closing conditions. With over 30 years of experience in the promotional products industry, Premier NYC brings deep experience creating and implementing...

Continue reading

Xenon Pharmaceuticals Provides Updates on Proprietary Neurology Pipeline Programs at the Annual Meeting of the American Epilepsy Society (AES 2022)

Company Presents Additional Positive Data from Open Label Extension of Phase 2b ‘X-TOLE’ Clinical Trial for Focal Onset Seizures XEN1101 Phase 3 Program to be Showcased at Scientific Exhibit Taking Place on Sunday, December 4, 2022 BURNABY, British Columbia, Dec. 02, 2022 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neurology-focused biopharmaceutical company, today announced it will provide updates on its proprietary, neurology programs at the Annual Meeting of the American Epilepsy Society (AES 2022). In addition, the Company is presenting results from the open label extension (OLE) and sub-analyses of data from the XEN1101 Phase 2b X-TOLE clinical trial. Mr. Ian Mortimer, Xenon’s President and Chief Executive Officer stated, “We continue to advance our portfolio of neurology-focused programs. Xenon will have...

Continue reading

URBN Announces Personnel Changes

PHILADELPHIA, Dec. 02, 2022 (GLOBE NEWSWIRE) — Urban Outfitters, Inc. (NASDAQ:URBN), today announced that Francis Pierrel, President, Urban Outfitters Group, has left the Company. We appreciate the contributions he made during his tenure and wish him well in his future endeavors. Urban Outfitters, Inc. offers lifestyle-oriented general merchandise and consumer products and services through a portfolio of global consumer brands comprised of the Anthropologie, BHLDN, Free People, FP Movement, Terrain, Urban Outfitters, Nuuly and Menus & Venues brands. This news release is being made pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995. Certain matters contained in this release may contain forward-looking statements. When used in this release, the words “project,” “believe,” “plan,”...

Continue reading

Gulf Resources Announces Buy Back of shares from Company’s CEO, CFO and COO

SHOUGUANG, China, Dec. 02, 2022 (GLOBE NEWSWIRE) — Gulf Resources, Inc. (Nasdaq: GURE) (“Gulf Resources”, “we,” or the “Company”), a leading manufacturer of bromine, crude salt and specialty chemical products in China announced that the Company has entered into a stock repurchase agreement dated as of November 30, 2022, in which the Company agrees to purchase 80,000 shares from each of CEO Xiaobin Liu, COO Naihui Miao, and CFO Min Li in a privately negotiated transaction based on the closing price of the stock of $3.5931 per share on Wednesday, November 30, 2022.The closing of the repurchase transactions is expected to occur in December 2022 and subject to customary closing conditions. Over the past year, the Company has received communications from many investors who have been concerned about the potential...

Continue reading

Navitas to Participate in China Renaissance, Fubon Securities, and CICC Investor Meetings

Navitas recently ranked 75th fastest-growing company in North America on the 2022 Deloitte Technology Fast 500™, continued growth advances mission to “Electrify Our World™”Navitas to Participate in China Renaissance, Fubon Securities, and CICC Investor Meetings Navitas recently ranked 75th fastest-growing company in North America on the 2022 Deloitte Technology Fast 500™, continued growth advances mission to “Electrify Our World™”TORRANCE, Calif., Dec. 02, 2022 (GLOBE NEWSWIRE) — Navitas Semiconductor (Nasdaq: NVTS), the only pure-play, next-generation power semiconductor company and industry leader in gallium nitride (GaN) power ICs and silicon carbide (SiC) technology, has announced participation in three upcoming investor conferences. China RenaissanceDecember 6th, from 9 am – noon (Hong Kong...

Continue reading

Dr. Nissan Cohen, ex-Founder/CEO of Tower Semiconductor, Joins Nano Dimension’s Board of Directors

Industry veteran, entrepreneur, and an investor Waltham, Mass., Dec. 02, 2022 (GLOBE NEWSWIRE) — Nano Dimension Ltd. (Nasdaq: NNDM, “Nano Dimension” or the “Company”), a leading supplier of Additively Manufactured Electronics (“AME”) and multi-dimensional polymer, metal & ceramic Additive Manufacturing (“AM”) 3D printers, announces the appointment of Dr. Nissan Cohen to the Board of Directors of the Company, effective immediately.  Dr. Yoav Nissan-Cohen will replace Mr. Yaron Eitan, who has served on the board of Nano Dimension since March 2020 and has stepped down as Dr. Nissan-Cohen joined. “I am very excited to join Nano Dimension’s Board of Directors. The Company has a truly transformative vision for the future of manufacturing and an exceptionally qualified and professional team.  I am looking forward to helping...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.